Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Akira Maruyama is active.

Publication


Featured researches published by Akira Maruyama.


Biochemical and Biophysical Research Communications | 1981

Potent inhibition of thrombin by the newly synthesized arginine derivative No. 805. The importance of stereo-structure of its hydrophobic carboxamide portion

Shosuke Okamoto; Akiko Hijikata; Ryoji Kikumoto; Shinji Tonomura; Hiroto Hara; Kunihiro Ninomiya; Akira Maruyama; Mamoru Sugano; Yoshikuni Tamao

Abstract Four stereoisomers of 4-methyl-1-[N 2 -(3-methyl-1,2,3,4-tetrahydro-8-quinolinesulfonyl)-L-arginyl]-2-piperidinecarboxylic acid were synthesized and examined for the inhibitory effect on thrombin. The inhibitory potency varied largely with the stereo-configuration of the 4-methyl-2-piperidinecarboxylic acid portion. The (2R, 4R)-isomer was the most potent inhibitor with a Ki of 0.019 μM, while the (2R, 4S) and (2S, 4R)-isomers showed the values of Ki 0.24 and 1.9 μM, respectively. The least potent inhibitor, (2S, 4S)-isomer, showed a Ki of 280 μM which is approximately 15,000 times that of (2R, 4R)-isomer.


Journal of Medicinal Chemistry | 1991

Synthesis and evaluation of antiinflammatory activities of a series of corticosteroid 17.alpha.-esters containing a functional group

Hiroaki Ueno; Akira Maruyama; Motoyoshi Miyake; Etsuko Nakao; Kenichiro Nakao; Kohei Umezu; Issei Nitta


Archive | 1993

Thieno[3,2-b]pyridine derivatives

Akira Maruyama; Shigeru Ogawa; Satoshi Yamazaki; Akihiro Tobe


Archive | 1984

Novel corticoid derivatives and process for production thereof

Issei Nitta; Kenichiro Nakao; Motoyoshi Miyake; Akira Maruyama; Junko Takashima; Hiroaki Ueno


Archive | 1987

Arginine derivatives and pharmaceutically acceptable acid addition salts thereof

Ryoji Kikumoto; Yoshikuni Tamao; Shinji Tonomura; Akira Maruyama; Shosuke Okamoto; Akiko Okunomiya


Archive | 1985

Trypsin-inhibiting arginine derivatives

Ryoji Kikumoto; Akira Maruyama; Shosuke Okamoto; Akiko Okunomiya; Yoshikuni Tamao; Shinji Tonomura


Archive | 1999

Crystals of 5-[{6-(2-fluorobenzyl)oxy-2-naphthyl}methyl]-2,4-thiazolidinedione

Takayuki Oe; Hiroaki Ueno; Akira Maruyama; Katsuhiko Masuda


Archive | 1999

5-ä(6-(2-fluorbenzyl)oxy-2-naphtyl)methylü-thiazolid in-2,4-dion kristallen crystalline 5-a (6- (2-fluorobenzyl) oxy-2-naphthyl) methylü-thiazolide in-2,4-dione

Takayuki Oe; Hiroaki Ueno; Akira Maruyama; Katsuhiko Masuda


Archive | 1993

Thieno(3,2-b)Pyridinderivate zur Behandlung von Magen-Darmstörungen Thieno (3,2-b) pyridine derivatives for the treatment of gastrointestinal disorders

Akira Maruyama; Shigeru Ogawa; Satoshi Yamazaki; Akihiro Tobe


Archive | 1993

Cinnolin-3-Carbonsäurederivate als 5-HT3-Antagonisten Cinnoline-3-carboxylic acid derivatives as 5-HT3 antagonists

Akira Maruyama; Shigeru Ogawa; Satoshi Yamazaki; Akihiro Tobe

Collaboration


Dive into the Akira Maruyama's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge